Could a simple sugar monitor extend life for deadly brain cancer patients?
NCT ID NCT07091864
Summary
This study is testing whether using a continuous glucose monitor (CGM) can help people with glioblastoma, a serious brain cancer, manage their blood sugar levels during treatment. High blood sugar during radiation is linked to worse survival, and steroids used in treatment often cause it. The CGM is a small sensor placed under the skin that provides real-time sugar readings, allowing for quicker adjustments. The goal is to see if better sugar control can help patients live longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA, IDH-WILDTYPE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.